Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IA › Ames › NPI 1639135643
Clinic

Mcfarland Clinic PC

Mcfarland Clinic PC was paid $26.67M by Medicaid between Jan 2018 and Dec 2024, across 252 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.

33Billing provider infoMCFARLAND CLINIC PC
AMES, IA 50010
33aNPI1639135643assigned 04/26/2006
28Total paid$26.67M
24GClaims887,467
24DCodes billed252
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Multi-Specialty Clinic/Center providers in Iowa

Rank by total paid#1 of 10
Median peer was paid$48K
This provider vs. median559×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018102,924$3.33M
2019113,077$3.76M
202093,263$3.13M
2021137,164$4.27M
2022157,594$4.69M
2023154,961$4.15M
2024incomplete128,484$3.34M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 26% 207,800 190,821 $7.03M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 17% 102,970 93,589 $4.60M
90460 Immunization administration through 18 years of age via any route, first or only component 6.5% 42,105 40,758 $1.72M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.7% 13,075 12,630 $1.52M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.8% 16,423 15,831 $1.27M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 3.4% 11,632 11,470 $897K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 3.0% 11,648 10,802 $800K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 2.8% 14,211 13,778 $754K
88305 Level IV - Surgical pathology, gross and microscopic examination 1.8% 6,873 5,392 $489K
J0475 Injection, baclofen, 10 mg 1.8% 876 852 $484K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1.8% 6,195 6,089 $470K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.3% 4,619 4,470 $349K
240 more codes
71046 Radiologic examination, chest; 2 views 1.2% 22,885 $318K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1.2% 3,645 $307K
95004 Percutaneous tests with allergenic extracts, immediate type reaction 1.1% 2,751 $290K
99204 Doctor's office visit, new patient (more involved) <1% 2,739 $239K
99203 Doctor's office visit, new patient (routine) <1% 3,586 $231K
96127 <1% 6,533 $221K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,377 $189K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 2,102 $188K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 11,063 $183K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 3,998 $172K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,021 $149K
88142 <1% 6,081 $140K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 14,981 $136K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 8,302 $130K
90461 <1% 16,242 $130K
90686 <1% 25,880 $129K
99239 Hospital discharge day management, more than 30 minutes <1% 1,638 $117K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 217 $112K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 4,277 $111K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 9,222 $109K
36415 Collection of venous blood by venipuncture <1% 40,937 $106K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 2,358 $97K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 6,358 $97K
70450 Computed tomography, head or brain; without contrast material <1% 2,824 $93K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 5,574 $89K
11721 <1% 6,363 $86K
73630 <1% 5,528 $84K
88307 <1% 758 $83K
T1013 Sign language or oral interpretive services, per 15 minutes <1% 2,908 $75K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,965 $73K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 7,835 $71K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 9,378 $67K
92567 <1% 3,829 $65K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,480 $62K
80053 Comprehensive metabolic panel <1% 5,498 $59K
99309 Subsequent nursing facility care, per day, low to moderate complexity <1% 5,250 $58K
99232 Hospital visit by a doctor, follow-up day <1% 1,767 $56K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,948 $52K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 998 $50K
71045 Radiologic examination, chest; single view <1% 7,911 $48K
99460 <1% 755 $45K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 209 $44K
20610 <1% 839 $42K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 765 $37K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 207 $37K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 346 $35K
73610 <1% 2,232 $33K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 184 $33K
80061 Lipid panel <1% 2,250 $31K
87081 <1% 3,796 $29K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 479 $24K
99223 Prolong inpt eval add15 m <1% 238 $23K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 302 $23K
95117 <1% 1,693 $23K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 356 $21K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 441 $20K
90480 <1% 789 $20K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 540 $19K
0071A <1% 478 $19K
73560 <1% 1,308 $19K
95811 <1% 127 $18K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 376 $18K
S0280 Medical home program, comprehensive care coordination and planning, initial plan <1% 368 $17K
84443 Thyroid stimulating hormone (TSH) <1% 943 $17K
95990 <1% 564 $16K
0072A <1% 391 $16K
80050 General health panel <1% 375 $15K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 117 $15K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 276 $15K
73110 <1% 861 $14K
90961 <1% 412 $13K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 160 $13K
95251 <1% 249 $13K
73030 <1% 804 $13K
83036 Hemoglobin; glycosylated (A1C) <1% 1,709 $11K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 203 $11K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 716 $11K
99238 Hospital discharge day management, 30 minutes or less <1% 191 $10K
84439 <1% 1,135 $10K
90960 End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits <1% 130 $9K
96367 <1% 356 $9K
0001A <1% 258 $9K
90670 <1% 5,822 $9K
99308 Subsequent nursing facility care, per day, straightforward <1% 2,512 $9K
74019 <1% 594 $9K
0002A <1% 232 $9K
00170 Anesthesia for intraoral procedures, including biopsy <1% 37 $9K
3074F <1% 70,275 $8K
90656 <1% 2,021 $8K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 222 $8K
73130 <1% 546 $8K
62323 <1% 50 $7K
90651 <1% 344 $7K
0012A <1% 197 $7K
74018 <1% 431 $7K
88141 <1% 280 $6K
83655 <1% 362 $6K
86140 <1% 926 $6K
99215 Doctor's office visit, returning patient (complex) <1% 121 $6K
0011A <1% 200 $6K
76830 Ultrasound, transvaginal <1% 103 $5K
G0444 Annual depression screening, 5 to 15 minutes <1% 385 $5K
72100 <1% 299 $5K
3078F <1% 32,010 $5K
95024 <1% 124 $5K
87581 <1% 112 $5K
J2469 Injection, palonosetron hcl, 25 mcg <1% 17 $5K
31231 <1% 66 $5K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 80 $4K
91321 <1% 154 $4K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 95 $4K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 97 $4K
20553 <1% 106 $4K
87631 <1% 51 $4K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 52 $4K
92015 Determination of refractive state <1% 275 $4K
73562 <1% 218 $4K
83735 <1% 527 $3K
96161 <1% 488 $3K
92551 <1% 244 $3K
54150 <1% 36 $3K
99462 <1% 106 $3K
90619 <1% 143 $3K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 44 $3K
90734 <1% 168 $3K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 483 $3K
92134 <1% 176 $3K
67028 Intravitreal injection of a pharmacologic agent <1% 29 $3K
87807 <1% 191 $3K
73502 <1% 167 $3K
95991 <1% 68 $3K
0054A <1% 73 $3K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 64 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 63 $3K
88304 <1% 98 $3K
93000 <1% 145 $3K
94060 <1% 78 $3K
90472 Immunization administration, each additional vaccine (list separately) <1% 151 $3K
73140 <1% 189 $3K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 50 $2K
85651 <1% 525 $2K
V2020 Frames, purchases <1% 93 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 39 $2K
01967 Neuraxial labor analgesia/anesthesia for planned vaginal delivery <1% 12 $2K
85018 <1% 694 $2K
99381 <1% 36 $2K
62370 <1% 29 $2K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 97 $2K
31575 <1% 25 $2K
90677 <1% 572 $2K
0124A <1% 56 $2K
99152 <1% 137 $1K
99188 <1% 98 $1K
11102 <1% 25 $1K
80069 <1% 151 $1K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 12 $1K
90685 <1% 684 $1K
94010 <1% 64 $1K
72125 Computed tomography, cervical spine; without contrast material <1% 28 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 75 $1K
A9585 Injection, gadobutrol, 0.1 ml <1% 48 $1K
85027 <1% 130 $1K
99385 <1% 12 $1K
96375 Therapeutic injection; each additional sequential IV push <1% 59 $1K
76801 <1% 12 $999.96
85652 <1% 288 $981.30
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 256 $933.86
3079F <1% 2,495 $900.00
0064A <1% 25 $852.80
90633 <1% 759 $782.32
90710 <1% 38 $769.55
97162 <1% 13 $745.78
80048 Basic metabolic panel (calcium, ionized) <1% 136 $744.74
L4361 Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf <1% 12 $738.40
99307 <1% 36 $721.89
86738 <1% 49 $687.13
76536 <1% 13 $610.83
92250 <1% 108 $606.75
71275 Computed tomographic angiography, chest, with contrast material <1% 12 $599.54
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 12 $590.57
82728 <1% 40 $576.14
90717 <1% 15 $535.90
0004A <1% 14 $528.00
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 43 $515.51
69210 <1% 12 $472.86
90715 <1% 43 $426.39
90698 <1% 2,055 $366.10
87086 Culture, bacterial; quantitative colony count, urine <1% 39 $362.01
0081A <1% 14 $323.20
87510 <1% 12 $322.42
87480 <1% 12 $322.42
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 14 $319.54
87660 <1% 12 $316.33
90697 <1% 349 $304.28
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 336 $272.82
82570 <1% 55 $261.18
V2103 Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens <1% 12 $256.88
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit <1% 12 $250.98
0154A <1% 12 $242.40
81001 <1% 50 $225.08
83550 <1% 26 $211.79
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 12 $209.36
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 12 $203.15
80076 <1% 24 $188.65
83540 <1% 26 $181.62
J1040 Injection, methylprednisolone acetate, 80 mg <1% 14 $160.17
82565 <1% 24 $132.96
80047 <1% 12 $131.91
93296 <1% 12 $125.87
86431 <1% 15 $111.03
90744 <1% 510 $109.58
90680 <1% 3,040 $93.00
81003 <1% 31 $89.56
84156 <1% 14 $63.95
V2756 Eye glass case <1% 67 $60.48
90648 <1% 12 $55.52
99310 Prolong nursin fac eval 15m <1% 17 $52.36
82043 <1% 15 $49.48
85014 <1% 12 $36.93
3044F <1% 44 $20.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 29 $9.46
0502F <1% 5,090 $0.01
99024 0% 764 $0.00
91307 0% 1,109 $0.00
3075F 0% 117 $0.00
G0008 Administration of influenza virus vaccine 0% 137 $0.00
91301 0% 389 $0.00
91305 0% 155 $0.00
91306 0% 13 $0.00
90716 0% 41 $0.00
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit 0% 18 $0.00
91315 0% 12 $0.00
90696 0% 12 $0.00
91300 0% 716 $0.00
91312 0% 40 $0.00
90707 0% 27 $0.00
91308 0% 105 $0.00
90700 0% 27 $0.00
90662 0% 33 $0.00
99177 0% 19 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPERRY, ANDREW (CEO)